The effect of reducing heart rate on central aortic blood pressure: a comparative study of ivabradine and atenolol on haemodynamic parameters at rest

Trial Profile

The effect of reducing heart rate on central aortic blood pressure: a comparative study of ivabradine and atenolol on haemodynamic parameters at rest

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2012

At a glance

  • Drugs Atenolol (Primary) ; Ivabradine (Primary)
  • Indications Cardiovascular disorders; Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 14 Sep 2012 Status changed from completed to discontinued as reported by ISRCTN.
    • 01 Jul 2009 Status changed from unconfirmed to completed as reported by ISRCTN.
    • 01 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top